Stay updated on Study of ZN-c3 in Solid Tumors Clinical Trial
Sign up to get notified when there's something new on the Study of ZN-c3 in Solid Tumors Clinical Trial page.

Latest updates to the Study of ZN-c3 in Solid Tumors Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoChange DetectedThe study record for the Phase 1 Azenosertib (ZN-c3) trial in participants with solid tumors is displayed, including its completed status, study design, eligibility criteria, locations, and outcome measures.SummaryDifference48%

- Check17 days agoChange DetectedThe site footer revision changed from v3.7.2 to v3.8.0 while the page continued to display a 403 Forbidden error.SummaryDifference0.2%

- Check24 days agoChange DetectedA notice appears announcing updates to NIH websites and explaining that some content may use “Super Intelligence” instead of “Artificial Intelligence” during the transition.SummaryDifference1%

- Check31 days agoChange DetectedThe footer revision identifier advances from v3.7.1 to v3.7.2.SummaryDifference0.2%

- Check38 days agoChange DetectedThe footer’s ClinicalTrials.gov revision identifier changed from v3.7.0 to v3.7.1 on the 403 Forbidden page.SummaryDifference0.2%

- Check58 days agoChange DetectedThe page now displays a 403 Forbidden error, replacing the expected study record content and indicating restricted access to the study record.SummaryDifference18%

Stay in the know with updates to Study of ZN-c3 in Solid Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Study of ZN-c3 in Solid Tumors Clinical Trial page.